IQVIA Holdings | IQV - Assets


IQVIA Holdings reported $29.88B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Accenture USD 68.81B 1.74B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Bruker USD 6.05B 77.8M Jun/2026
Cardinal Health USD 57.3B 610M Jun/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Cigna USD 157.08B 3.82B Jun/2026
Cognizant Technology Solutions USD 20.83B 325M Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
CVS Health USD 253.77B 794M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Elevance Health USD 126.44B 611M Jun/2026
Humana USD 57.2B 1.92B Jun/2026
IBM USD 152.1B 4.13B Jun/2026
Illumina USD 6.65B 91M Jun/2026
Infosys INR 4.4B 1.43T Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Laboratory Of America USD 18.53B 554.8M Jun/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
McKesson USD 88.33B 6.01B Jun/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pharma Mar EUR 393.6M 8.34M Jun/2026
Publicis EUR 40.14B 128M Jun/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
Sartorius EUR 9.6B 270.6M Jun/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025
UnitedHealth USD 309.73B 2.92B Jun/2026
Veeva Systems USD 9.13B 150.22M Mar/2026
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 24.75B 220M Jun/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026